Skip to main content
Premium Trial:

Request an Annual Quote

John Berriman, Albert Friesen, Phiet Bui, Jim Charlton, Peter de Visser, Ted Paetkau, Ronald Beavis

Premium
John Berriman was appointed chairman of Pronota’s board this week. Berriman is chairman of Algeta ASA and a board member of MicroMet, Ablynx and Oxxon Therapeutics Holdings. Based in Ghent, Belgium, Pronota, formerly known as Peakadilly, provides protein discovery and analysis services and conducts its own blood-based biomarker discovery.
 

 
Miraculins this week announced the reelection of the following to the company’s board: Albert Friesen; Phiet Bui; Jim Charlton; Peter de Visser; and Ted Paetkau.
 

 
Ronald Beavis was appointed Canada Research Chair in Experimental Bioinformatics, the University of British Columbia announced this week. Beavis is a member of the university’s Biomedical Research Center and is working on creating a library of peptides. The chair is a federally funded research position and is designed to build Canada’s research capacity.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.